Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Total 13F shares
-
913,904
-
Share change
-
-12,902
-
Total reported value
-
$129,017
-
Price per share
-
$0.14
-
Number of holders
-
6
-
Value change
-
-$1,793
-
Number of buys
-
1
-
Number of sells
-
3
Institutional Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q1 2025
As of 31 Mar 2025,
Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
913,904 shares.
The largest 6 holders included
Walleye Capital LLC, TENOR CAPITAL MANAGEMENT Co., L.P., ZAZOVE ASSOCIATES LLC, Walleye Trading LLC, JPMORGAN CHASE & CO, and UBS Group AG.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.